Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-May-24 7:24 PM View:  | Nivalis Therapeutics, Inc. (ALPN) | 08-May-24 | Option Exercise | 13,245 | $7.55 | $99,999.80 | < 1% 2.72M to 2.74M | |
| 05-Jan-24 6:08 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 04-Jan-24 | Grant | 96,000 | -- | -- | 4% 2.63M to 2.72M | |
| 29-Dec-23 7:32 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-23 | Payment of Exercise | 48,264 | $19.65 | $948,388.00 | (2%) 2.68M to 2.63M | |
| 29-Dec-23 7:32 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-23 | Option Exercise | 74,441 | $12.74 | $948,378.00 | 3% 2.6M to 2.68M | |
| 29-Dec-23 7:32 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-23 | Option Exercise | 1,016 | $0.65 | $660.40 | < 1% 2.68M to 2.68M | |
| 29-Dec-23 7:32 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-23 | Planned Option Sale | 1,016 | $20.04 | $20,362.00 | (< 1%) 2.63M to 2.63M | |
| 27-Dec-23 9:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 27-Dec-23 | Option Exercise | 29,573 | $0.65 | $19,222.40 | 1% 2.6M to 2.63M | |
| 27-Dec-23 9:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 27-Dec-23 | Planned Option Sale | 29,573 | $20.04 | $592,717.00 | (1%) 2.63M to 2.6M | |
| 27-Dec-23 9:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 26-Dec-23 | Option Exercise | 24,486 | $0.63 | $15,435.50 | < 1% 2.6M to 2.63M | |
| 27-Dec-23 9:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 26-Dec-23 | Planned Option Sale | 24,486 | $20.22 | $495,217.00 | (< 1%) 2.63M to 2.6M | |
| 27-Dec-23 9:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Dec-23 | Option Exercise | 37,825 | $0.45 | $17,021.20 | 1% 2.6M to 2.64M | |
| 27-Dec-23 9:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Dec-23 | Planned Option Sale | 37,825 | $20.43 | $772,595.00 | (1%) 2.64M to 2.6M | |
| 21-Dec-23 7:34 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 19-Dec-23 | Option Exercise | 2,402 | $0.45 | $1,080.90 | < 1% 2.6M to 2.6M | |
| 21-Dec-23 7:34 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 19-Dec-23 | Planned Option Sale | 2,402 | $20.01 | $48,063.80 | (< 1%) 2.6M to 2.6M | |
| 12-Dec-23 9:02 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 12-Dec-23 | Option Exercise | 8,613 | $0.45 | $3,875.85 | < 1% 2.63M to 2.64M | |
| 12-Dec-23 9:02 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 12-Dec-23 | Sale (Planned) | 41,063 | $17.32 | $711,026.00 | (2%) 2.64M to 2.6M | |
| 12-Dec-23 9:02 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 11-Dec-23 | Planned Option Sale | 8,613 | $17.26 | $148,702.00 | (< 1%) 2.7M to 2.69M | |
| 12-Dec-23 9:02 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 11-Dec-23 | Sale (Planned) | 60,257 | $17.26 | $1,040,320.00 | (2%) 2.69M to 2.63M | |
| 12-Dec-23 9:02 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 08-Dec-23 | Private Sale (Planned) | 8,067 | $17.08 | $137,784.00 | (< 1%) 2.71M to 2.7M | |
| 21-Sep-21 10:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 17-Sep-21 | Market Sale Duplicate | 400,000 | $9.40 | $3,760,000.00 | (13%) 3.16M to 2.76M | (10%) |
| 21-Sep-21 10:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 17-Sep-21 | Market Sale (Planned) | 45,262 | $10.01 | $452,964.00 | (2%) 2.76M to 2.71M | (4%) |
| 17-Sep-21 6:06 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 16-Sep-21 | Market Sale (Planned) | 6,768 | $10.00 | $67,696.20 | (< 1%) 3.16M to 3.16M | < 1% |
| 17-Sep-21 6:06 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 15-Sep-21 | Market Sale (Planned) | 3,484 | $10.00 | $34,840.00 | (< 1%) 3.17M to 3.16M | < 1% |
| 29-Jun-21 5:13 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Jun-21 | Market Sale (Planned) | 3,479 | $10.00 | $34,791.70 | (< 1%) 3.17M to 3.17M | 6% |
| 29-Jun-21 5:13 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 25-Jun-21 | Market Sale (Planned) | 9,473 | $10.01 | $94,865.50 | (< 1%) 3.18M to 3.17M | 7% |
| 21-May-21 5:16 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 20-May-21 | Market Sale (Planned) | 1,221 | $15.00 | $18,315.70 | (< 1%) 3.18M to 3.18M | 16% |
| 21-May-21 5:16 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 19-May-21 | Market Sale (Planned) | 50,965 | $15.03 | $765,917.00 | (2%) 3.23M to 3.18M | 17% |
| 14-May-21 5:17 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 13-May-21 | Market Sale (Planned) | 10,000 | $11.52 | $115,169.00 | (< 1%) 3.24M to 3.23M | < 1% |
| 14-May-21 5:17 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 12-May-21 | Market Sale (Planned) | 10,000 | $11.68 | $116,842.00 | (< 1%) 3.25M to 3.24M | 2% |
| 15-Apr-21 6:09 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 14-Apr-21 | Market Sale (Planned) | 10,000 | $10.52 | $105,200.00 | (< 1%) 3.26M to 3.25M | (7%) |
| 15-Apr-21 6:09 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 13-Apr-21 | Market Sale (Planned) | 10,000 | $10.07 | $100,714.00 | (< 1%) 3.27M to 3.26M | (12%) |
| 08-Mar-21 5:01 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 05-Mar-21 | Market Sale (Planned) | 10,000 | $12.99 | $129,875.00 | (< 1%) 3.28M to 3.27M | < 1% |
| 08-Mar-21 5:01 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 04-Mar-21 | Market Sale (Planned) | 10,000 | $13.01 | $130,108.00 | (< 1%) 3.29M to 3.28M | < 1% |
| 03-Feb-21 5:01 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 02-Feb-21 | Market Sale (Planned) | 10,000 | $11.74 | $117,381.00 | (< 1%) 3.3M to 3.29M | < 1% |
| 03-Feb-21 5:01 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 01-Feb-21 | Market Sale (Planned) | 10,000 | $12.87 | $128,665.00 | (< 1%) 3.31M to 3.3M | 10% |
| 04-Jan-21 8:37 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 31-Dec-20 | Payment of Exercise | 11,123 | $12.60 | $140,150.00 | (< 1%) 3.32M to 3.31M | < 1% |
| 22-Dec-20 5:30 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Dec-20 | Acquisition (other) | 260,528 | -- | -- | 6% 4.06M to 4.32M | |
| 22-Dec-20 5:30 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Dec-20 | Disposition (other) Duplicate | 993,801 | -- | -- | (23%) 4.32M to 3.32M | |
| 01-Jul-20 7:24 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-Jun-20 | Payment of Exercise | 8,227 | $9.71 | $79,884.20 | (< 1%) 4.06M to 4.06M | (64%) |
| 27-Jan-20 6:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Jan-20 | Grant | 67,569 | -- | -- | 2% 4.0M to 4.06M | |
| 27-Jan-20 6:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Dec-19 | Gift | 5,000 | -- | -- | (< 1%) 4.0M to 4.0M | |
| 27-Jan-20 6:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 11-Dec-19 | Gift | 5,000 | -- | -- | (< 1%) 4.01M to 4.0M | |
| 22-Jan-19 8:44 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Jan-19 | Market Purchase Duplicate | 190,875 | $5.37 | $1,025,000.00 | 5% 3.82M to 4.01M | 198% |
| 22-Jan-19 8:44 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 21-May-18 | Gift | 6,000 | -- | -- | (< 1%) 3.82M to 3.82M | |
| 22-Jan-19 8:44 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 15-May-18 | Gift | 3,000 | -- | -- | (< 1%) 3.82M to 3.82M | |
| 22-Jan-19 8:44 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 14-May-18 | Gift | 3,000 | -- | -- | (< 1%) 3.83M to 3.82M | |
| 26-Jul-17 5:13 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 24-Jul-17 | Grant | 23,292 | -- | -- | 100% 0 to 23.29K | |
| 26-Jul-17 5:13 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 24-Jul-17 | Acquisition (other) | 3,878,440 | -- | -- | 16651% 23.29K to 3.9M | |
| 07-Jan-13 5:09 PM View: | Dendreon Corp. (DNDN) | 03-Jan-13 | Grant | 25,000 | -- | -- | 6% 432.26K to 457.26K | |
| 03-Jul-12 12:16 PM View: | Dendreon Corp. (DNDN) | 30-Jun-12 | Payment of Exercise | 197,764 | $7.40 | $1,463,450.00 | (31%) 630.03K to 432.26K | 99% |